| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |